NervGen Pharma Corp. (NGEN)
NASDAQ: NGEN · Real-Time Price · USD
1.395
+0.065 (4.89%)
At close: Nov 9, 2026, 4:00 PM EST
1.420
+0.025 (1.79%)
Pre-market: Nov 10, 2026, 7:07 AM EST
NervGen Pharma Market Cap
NervGen Pharma has a market cap or net worth of $149.99 million as of November 9, 2026. It is the 22,311th most valuable company in the world and the 3,772nd biggest in the United States. Its market cap has decreased by 17.11% in one year.
Market Cap
149.99M
Enterprise Value
88.88M
1-Year Change
-17.11%
Global Rank
Country Rank
#3,772 United States
Category
ChartMarket Cap Chart
Since April 3, 2019, NervGen Pharma's market cap has increased from $37.43M to $149.99M, an increase of 300.73%. That is a compound annual growth rate of 20.02%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 9, 2026 | 149.99M | -66.35% |
| Dec 31, 2025 | 445.73M | 190.81% |
| Dec 31, 2024 | 153.27M | 26.05% |
| Dec 29, 2023 | 121.60M | 74.14% |
| Dec 30, 2022 | 69.83M | -27.73% |
| Dec 31, 2021 | 96.62M | 58.13% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Apr 3, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Satellos Bioscience | 152.30M |
| AN2 Therapeutics | 150.94M |
| MacroGenics | 148.42M |
| Sionna Therapeutics | 148.30M |
| Yarrow Bioscience | 145.15M |
| Atrium Therapeutics | 142.66M |
| Compass Therapeutics | 136.65M |
| Cue Biopharma | 136.06M |